141 related articles for article (PubMed ID: 38797685)
1. [Juvenile-onset anti-nuclear matrix protein 2 (NXP-2) antibody-positive dermatomyositis with joint contractures before manifestation of myositis: a case report].
Miura E; Taneda T; Umeda Y; Umeda M; Oyake M; Matsushita T; Nishino I; Fujita N
Rinsho Shinkeigaku; 2024 Jun; 64(6):417-421. PubMed ID: 38797685
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
[TBL] [Abstract][Full Text] [Related]
3. [A case of dermatomyositis positive for anti-nuclear matrix protein 2 antibody without dermatologic symptoms].
Takeuchi E; Hirozawa D; Okiyama N; Inoue M; Nishino I; Sugai F
Rinsho Shinkeigaku; 2021 Apr; 61(4):258-261. PubMed ID: 33762494
[TBL] [Abstract][Full Text] [Related]
4. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
[TBL] [Abstract][Full Text] [Related]
5. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
[TBL] [Abstract][Full Text] [Related]
6. [Two cases of anti-nuclear matrix protein 2 antibody-positive dermatomyositis sine dermatitis with severe diffuse subcutaneous edema and dysphagia].
Takahashi Y; Takamiya M; Ichimura Y; Okiyama N; Nishino I; Morimoto N
Rinsho Shinkeigaku; 2023 Nov; 63(11):737-742. PubMed ID: 37880118
[TBL] [Abstract][Full Text] [Related]
7. Perimysial microarteriopathy in dermatomyositis with anti-nuclear matrix protein-2 antibodies.
Liu Y; Zheng Y; Gang Q; Xie Z; Jin Y; Zhang X; Deng X; Hao H; Gao F; Zhang Z; Xiong H; Zhang W; Wang Z; Yuan Y
Eur J Neurol; 2020 Mar; 27(3):514-521. PubMed ID: 31571350
[TBL] [Abstract][Full Text] [Related]
8. Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients.
Albayda J; Pinal-Fernandez I; Huang W; Parks C; Paik J; Casciola-Rosen L; Danoff SK; Johnson C; Christopher-Stine L; Mammen AL
Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1771-1776. PubMed ID: 28085235
[TBL] [Abstract][Full Text] [Related]
9. Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report.
Nainia K; Aouzal MA; Ouafik I; Charhbili M; Bouchhab A; Daoudi A; Tizki S; Chakiri R
Pediatr Rheumatol Online J; 2024 May; 22(1):57. PubMed ID: 38773611
[TBL] [Abstract][Full Text] [Related]
10. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report.
Kishi T; Tani Y; Okiyama N; Mizuochi K; Ichimura Y; Harigai M; Nagata S; Miyamae T
Pediatr Rheumatol Online J; 2021 Mar; 19(1):34. PubMed ID: 33740993
[TBL] [Abstract][Full Text] [Related]
11. Nuclear matrix protein 2 antibody-positive adult dermatomyositis: a case report and review of the literature.
Cartron AM; Osler M; Chung C; Trinidad JC
Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609448
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients.
Rogers A; Chung L; Li S; Casciola-Rosen L; Fiorentino DF
Arthritis Care Res (Hoboken); 2017 Dec; 69(12):1909-1914. PubMed ID: 28129490
[TBL] [Abstract][Full Text] [Related]
13. Association of Dermatomyositis Sine Dermatitis With Anti-Nuclear Matrix Protein 2 Autoantibodies.
Inoue M; Tanboon J; Hirakawa S; Komaki H; Fukushima T; Awano H; Tajima T; Yamazaki K; Hayashi R; Mori T; Shibuya K; Yamanoi T; Yoshimura H; Ogawa T; Katayama A; Sugai F; Nakayama Y; Yamaguchi S; Hayashi S; Noguchi S; Tachimori H; Okiyama N; Fujimoto M; Nishino I
JAMA Neurol; 2020 Jul; 77(7):872-877. PubMed ID: 32310254
[TBL] [Abstract][Full Text] [Related]
14. Anti-NXP2 Antibody-positive Juvenile Dermatomyositis with Characteristic Fascial Thickening on Muscle Ultrasound and Improvement with Immunotherapy.
Fukushima K; Yoshida T; Yamazaki H; Takamatsu N; Nagai T; Osaki Y; Harada M; Nishino I; Okiyama N; Sugie K; Izumi Y
Intern Med; 2024 Jun; 63(12):1813-1817. PubMed ID: 37926535
[TBL] [Abstract][Full Text] [Related]
15. Anti-Mi-2 and Anti-TIF1-γ Double-Positive Juvenile Dermatomyositis Treated under Diagnosis of Chronic Eczema: A Case Report.
Yoshida S; Matsumoto H; Fujita Y; Yokose K; Temmoku J; Matsuoka N; Yashiro-Furuya M; Asano T; Sato S; Suzuki E; Yago T; Yaguchi T; Aita T; Kusano M; Yamamoto T; Watanabe H; Migita K
Tohoku J Exp Med; 2022 Apr; 256(4):303-308. PubMed ID: 35296571
[TBL] [Abstract][Full Text] [Related]
16. [A case of anti-nuclear matrix protein 2 antibody positive myopathy associated with lung cancer].
Ohta S; Unoda K; Nakajima H; Ikeda S; Hamaguchi Y; Kimura F
Rinsho Shinkeigaku; 2016 Aug; 56(8):573-6. PubMed ID: 27477574
[TBL] [Abstract][Full Text] [Related]
17. Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.
Fiorentino DF; Chung LS; Christopher-Stine L; Zaba L; Li S; Mammen AL; Rosen A; Casciola-Rosen L
Arthritis Rheum; 2013 Nov; 65(11):2954-62. PubMed ID: 24037894
[TBL] [Abstract][Full Text] [Related]
18. Possible correlation between serum interleukin-8 levels and the activity of myositis in anti-NXP2 antibody-positive dermatomyositis.
Konishi R; Ichimura Y; Tanaka R; Miyahara H; Okune M; Miyamoto M; Hara M; Iwabuchi A; Takada H; Nakagishi Y; Mizuta M; Kaneko S; Shimizu M; Morio T; Nishino I; Nomura T; Okiyama N
Immunol Med; 2024 Jun; 47(2):100-105. PubMed ID: 38174692
[TBL] [Abstract][Full Text] [Related]
19. Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review.
Yeung TW; Cheong KN; Lau YL; Tse KN
Pediatr Rheumatol Online J; 2021 Jun; 19(1):103. PubMed ID: 34193210
[TBL] [Abstract][Full Text] [Related]
20. Erythroderma and extensive poikiloderma - a rare initial presentation of dermatomyositis: a case report.
Herath HMMTB; Keragala BSDP; Pahalagamage SP; Janappriya GHCC; Kulatunga A; Gunasekera CN
J Med Case Rep; 2018 Mar; 12(1):83. PubMed ID: 29571300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
